title: [Contemporary approaches to the treatment of the irritable bowel syndrome in pilots].
abstract: Reported are results of treating 53 pilots with the irritated large intestine syndrome verified by endoscopic and morphologic investigations. Salozinal proved to be highly helpful to young patients. One of the therapeutic mechanisms is blocking of the cycloxygenase path circumstantially confirmed by normalization of lipid peroxidation and AOS owing to salozinal.
authors.forename: V N
authors.initials: VN
authors.lastname: Preobrazhenskiĭ
authors.forename: V V
authors.initials: VV
authors.lastname: Vasilenko
mesh_terms: D000328:Adult; D000337:Aerospace Medicine; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003109:Colonic Diseases, Functional / Q000188:drug therapy*; D006801:Humans; D007070:Immunoglobulin A / Q000097:blood; D007074:Immunoglobulin G / Q000097:blood; D008297:Male; D013026:Space Flight; D013256:Steroids; D012460:Sulfasalazine / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D013256:Steroids; D012460:Sulfasalazine